A recent study published in Heart Rhythm highlights how artificial intelligence (AI) algorithms embedded in Medtronic’s LINQ II implantable loop recorders (ILRs) significantly reduce alert and episode burdens. This is…
Encora Therapeutics is excited to announce the successful completion of the ULTRE (Upper Limb Tremor Reduction in Essential Tremor) clinical trial. The study assessed the safety, tolerability, and effectiveness of…
SOLVD Health, a patient intelligence company focused on precision solutions to improve health outcomes, has launched a comprehensive post-approval study for AvertD®, the first FDA-approved genetic test to assess the…
At the ISPOR Europe 2024 Conference, CapeStart, Inc. unveiled MadeAi™, a generative AI-powered platform designed to revolutionize the synthesis of clinical information. The platform’s first solution, MadeAi-LR, enhances the efficiency…
Vektor Medical, a leader in non-invasive arrhythmia analysis and localization, today announced new data demonstrating the enhanced capabilities of its AI-powered solution, vMap, for improving cardiac arrhythmia treatment. The data,…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, today announced that its OSPREY randomized controlled trial (RCT) met its primary safety and efficacy endpoints. The trial, which evaluated the…
TriSalus Life Sciences® Inc. (Nasdaq: TLSI), an oncology-focused company committed to improving outcomes for liver cancer patients through its advanced drug delivery technology and investigational immunotherapy nelitolimod, has entered into…
In recognition of National Nurse Practitioner Week (November 10-16), Lindora is honoring the contributions of nurse practitioners and wellness professionals with a special offer. There are over 385,000 nurse practitioners…
Butterfly Network, Inc. (NYSE: BFLY), a leader in digital health and portable ultrasound technology, has announced that its third-generation handheld ultrasound device, the Butterfly iQ3™, has been honored with the…
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, announced today the successful closing of a $78 million Series E funding round, led by Qingdao Baheal Medical…
Cofactor Genomics, Inc., a clinical-stage company focused on advancing precision medicine through RNA decoding, has announced the publication of results from its PREDAPT clinical trial (NCT04510129) in head and neck…
SBC Medical Group Holdings (California, USA, CEO: Aikawa Yoshiyuki), a provider of management support to medical institutions globally, has entered into a business partnership with MEDIROM Corporation (Headquarters: Minato-ku, Tokyo,…